Skip to content

A Multi-center, randomized, double-blinded, double-dummy, parallel-controlled clinical trial to determine the efficacy and safety of Tripterygium Glycosides and Acitretin in patients with generalized pustular psoriasis

Guideline-oriented Research in the Management of Some Common and Severe Skin Diseases

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12003542
Enrollment
Unknown
Registered
2012-12-18
Start date
2011-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized pustular psoriasis

Interventions

TG treatment group:Take TG tablet 2 slices every time, thrice a day, the placebo of Acitretin Capsules 2 pills every time, twice a day
Acitretin treatment group:Take the placebo of TG tablet 2 slices every time, thrice a day, Acitretin Capsules 2 pills every time, twice a day

Sponsors

Institute of dermatology, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Males and females aged between 16 and 75 years; 2. Patients who was diagnosed as generalized pustular psoriasis; 3. Provide written informed consent; 4. Willing and able to comply with all aspects of the protocol.

Exclusion criteria

Exclusion criteria: 1. Localized pustular psoriasis; 2. patients who has allergy of Tripterygium Glycosides and Acitretin any ingredient; 3. Patients who used any of the following systemic treatments within 4 weeks before the Baseline visit eg: corticosteroids, immuno-suppressive drugs, biologics; 4. History of hepatitis B or hepatitis C, and advanced HIV infection; 5. Laboratory data such as alanine aminotransferase (ALT), aspartate aminotransferase (AST) and blood lipid profile was 1.5 times higher than the normal limits.

Design outcomes

Primary

MeasureTime frame
The time of no new pustules and the old ones dried;Assessment for the pustule;

Secondary

MeasureTime frame
Skin symptoms and laboratory data of comprehensive;The time of white blood cell and CRP turned to be normalized;Temperature;ESR;hs CRP;

Countries

China

Contacts

Public ContactBaoxi Wang
wangbx@ncstdlc.org+86 025-85478071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026